Jim Cramer's top 10 things to watch in the stock market Thursday

Earnings and AI spending remain the dominant market catalyst, with Alphabet jumping 8%, Amazon up more than 3.5%, Microsoft down just over 1%, and Meta off more than 8.5% on mixed results and higher capex. Eli Lilly surged more than 6% after crushing estimates, while Qualcomm rose over 10% on plans to ship data center chips to a large hyperscaler. The Fed kept rates unchanged amid unusually high dissent, while 10-year yields above 4.43% and oil near $107/Brent over $118 previously pressured risk assets.

Analysis

The tape is telling us the market is rewarding the vendors that sit closest to hyperscaler capex, not just the hyperscalers themselves. GOOGL and AMZN look like the cleanest beneficiaries because their AI spend is already translating into monetizable throughput, while AVGO and QCOM are the real second-order winners as custom silicon shifts value from generic accelerators toward edge-to-cloud architecture and design wins. That creates a near-term relative-value tailwind for semis with content exposure to TPU/Trainium/custom data-center chips, while NVDA is more insulated than punished: the risk is not share loss today, but incremental pricing pressure and a longer digestion period if hyperscalers keep internalizing workloads.

META is the clearest counterexample: when the market cannot anchor capex to a direct cloud monetization line, higher spend becomes a margin problem instead of an efficiency story. The selloff suggests investors are becoming less tolerant of “AI optionality” without a visible payback path over the next 2-3 quarters. That is a useful signal for other ad-driven platforms and lower-visibility spenders: if revenue acceleration does not show up fast enough, multiple compression can arrive before the actual earnings damage.

The more interesting contrarian angle is that MSFT may be the most underappreciated setup despite the muted reaction. A pullback after a solid print plus continued capex intensity creates a favorable entry if the market later decides Copilot monetization is lagged rather than impaired. On the healthcare side, LLY’s volume-led strength reinforces that pricing power is less important than utilization growth; that is a positive read-through for high-demand chronic-care franchises and a warning that reimbursement pressure may be easier to absorb than feared over the next 12 months.

Macro remains a swing factor: lower oil and softer yields are doing equity beta a favor, but if yields back up again, the market will quickly rotate away from these duration-sensitive growth winners and punish the names with the least visible payback. For now, the cleanest expression is to own the AI capex enablers with real order visibility and fade the “spend without cloud-like monetization” stories.

Key Decisions for Investors

• Long AVGO vs short META for the next 4-8 weeks: AVGO has direct leverage to hyperscaler custom-chip spend while META is being repriced for capex without a comparable monetization offset; target 8-12% relative outperformance if AI capex leadership persists.
• Add on weakness to MSFT on a 1-2 week horizon: the stock’s muted reaction looks more like delayed monetization skepticism than fundamental deterioration; risk/reward improves if Copilot adoption or Azure reacceleration becomes a June-quarter talking point.
• Buy QCOM on pullbacks for a 1-3 month trade: the hyperscaler data-center chip narrative is a genuine multiple re-rating event, and even modest design-win confirmation could extend the move; downside is a guidance reset if the large-customer ramp slips.
• Maintain a tactical long GOOGL / AMZN basket over NVDA for the next earnings cycle: the market is currently paying more for visible monetization than for pure AI hardware leverage; if capex remains elevated, the cloud/platform owners should compound faster than the upstream picker.
• Use LLY strength as a signal to own quality healthcare cash-flow names on weakness over 3-6 months; the market is rewarding volume growth over pricing, which supports durable franchises with operating leverage even in a slower macro.